Oxifyl CR Tablet (Controlled Release) 400 mg (also known as PTX or Trental), is a medication that belongs to a group of drugs called xanthines. It works by making the blood cells more flexible, which improves blood flow and reduces the risk of blood clots. Oxifyl CR Tablet (Controlled Release) 400 mg is used to improve the symptoms of peripheral vascular disease, such as pain, numbness, and weakness in the legs. It may also be used to treat other conditions as determined by your doctor.
Oxifyl CR Tablet (Controlled Release) 400 mg is used to improve the symptoms of peripheral vascular disease. It is used to decrease symptoms such as pain, numbness, and weakness in the legs.
| Brand Name | Oxifyl CR |
|---|---|
| Type | Tablet (Controlled Release) |
| Weight | 400 mg |
| Generic | Pentoxifylline |
| Manufacturer | Square Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Oxifyl CR Tablet (Controlled Release) 400 mg works by making red blood cells more flexible, which reduces their tendency to stick together and clump. This improves blood flow, which can improve symptoms of peripheral vascular disease.
It typically takes several weeks of treatment before the benefits of pentoxifylline can be felt. The patient should discuss with their doctor if they do not experience any improvement after a few weeks of treatment.
Oxifyl CR Tablet (Controlled Release) 400 mg is absorbed from the gastrointestinal tract and primarily metabolized and eliminated in the urine. It is usually taken orally, in the form of tablets or capsules, three times per day. The adult dosage of pentoxifylline is 400mg to 600mg per day. Pediatric dosage of pentoxifylline is 20mg to 50mg per kilogram of body weight per day, depending on the condition being treated.
The most common side effects of pentoxifylline are headache, nausea, vomiting, diarrhea, increased heart rate, and dizziness. Patients should contact their doctor if they experience any severe side effects such as chest pain, difficulty breathing, confusion, irregular heartbeat, and swollen ankles or feet.
Oxifyl CR Tablet (Controlled Release) 400 mg can be toxic if taken in high doses. The risk of toxicity increases with higher doses. It is important for patients to follow the dosing instructions of their doctor to avoid potential toxicity.
Patients should discuss their medical history with their doctor before taking pentoxifylline. Patients should also be aware of potential drug interactions when taking this medication. Oxifyl CR Tablet (Controlled Release) 400 mg can interact with other drugs, including anticoagulants, hormonal medications, drugs for diabetes, and other xanthines. Additionally, pentoxifylline should not be used by patients with kidney or liver disease, a history of gastrointestinal bleeding, or certain blood disorders.
Oxifyl CR Tablet (Controlled Release) 400 mg can interact with certain diseases, such as anemia, diabetes, kidney or liver disease, or cardiovascular diseases. Patients should discuss these conditions with their doctor before taking pentoxifylline.
Oxifyl CR Tablet (Controlled Release) 400 mg can interact with other drugs, including anticoagulants, drugs for diabetes, and other xanthines. Patients should discuss all drug interactions with their doctor and should not take other medications without first consulting their doctor.
Oxifyl CR Tablet (Controlled Release) 400 mg can interact with certain foods, such as grapefruit, which can increase the risk of toxicity. Patients should discuss any food interactions with their doctor and be sure to read any labels before consuming any food or beverage.
Oxifyl CR Tablet (Controlled Release) 400 mg has not been studied in pregnant women, so there is a potential risk associated with taking this medication during pregnancy. Patients should only take pentoxifylline if the potential benefits outweigh the risks. Patients should discuss their individual risk with their doctor.
Oxifyl CR Tablet (Controlled Release) 400 mg has been found to be excreted in breastmilk. Therefore, it is not recommended for use while breastfeeding. Patients should discuss their individual risk with their doctor.
A single overdose of pentoxifylline can cause serious side effects and even death. Patients who have taken an overdose should seek medical attention immediately.
Oxifyl CR Tablet (Controlled Release) 400 mg is contraindicated in patients with known hypersensitivity to the drug. It is also contraindicated in patients with kidney or liver disease, a history of gastrointestinal bleeding, or certain blood disorders.
Patients should take pentoxifylline exactly as prescribed by their doctor. Patients should not exceed the recommended dose or take the medication for longer than recommended. The tablets should be swallowed whole with a full glass of water.
Oxifyl CR Tablet (Controlled Release) 400 mg should be stored at room temperature, away from light and moisture. It should be kept in a safe place, out of reach of children and pets.
The volume of distribution of pentoxifylline is approximately 3.5-5 L/kg.
The half-life of pentoxifylline is approximately 20-30 minutes.
The clearance of pentoxifylline is approximately 7-9 mL/min/kg.
See in details version Oxifyl CR Tablet (Controlled Release) 400 mg also Oxifyl CR Tablet (Controlled Release) 400 mg in bangla